Fractional Regulatory & Quality Leadership
Senior RA / QA guidance for Seed–Series B medical device teams — embedded in your rhythm, accountable to your milestones.
Helping early-stage device founders move confidently through FDA, TGA, and EU MDR pathways — without hiring too early.
Regulatory uncertainty costs time, capital, and credibility. Saunee gives you structure, clarity, and execution that investors and regulators trust.
Senior RA / QA guidance for Seed–Series B medical device teams — embedded in your rhythm, accountable to your milestones.
FDA 510(k), PMA, TGA, and EU MDR guidance grounded in real-world success — not framework theory.
ISO 13485 / QMSR-aligned systems that satisfy auditors and investors — scalable from first-in-human to first commercial shipment.
With experience across implantable systems, diagnostics, and digital health, we help you:
Regulatory isn't a checkbox — it's a strategic advantage when done right.
The firm is led by a global regulatory and quality executive with over a decade of experience bringing complex medical devices to market.
They have led FDA, TGA, and EU MDR programs for implantable, diagnostic, and digital health technologies, working at the intersection of engineering, clinical, and commercial teams. Their work has supported venture-backed startups as well as publicly listed medtech companies.
Before founding Saunee, the team held senior regulatory roles at companies building Class III implantable systems and global diagnostics platforms — where execution quality, not just regulatory theory, determined success.
Saunee exists to give founders the same level of regulatory clarity that large medtech companies take for granted — without the overhead.
We partner with you early and purposefully, keeping teams moving without unnecessary overhead. Our engagements typically follow a structured rhythm:
Rapid evaluation of your device, clinical intent, and regulatory exposure.
A clear, defensible regulatory roadmap tailored to your product and markets.
We help construct the QMS, evidence, and artifacts that regulators expect.
Ongoing advisory through submissions, audits, and investor diligence.
We embed with your team so decisions are informed, timely, and unambiguous.
Rapid review of your device, intended use, and regulatory context to clarify risk and opportunity.
You receive a written plan covering classification, pathway, milestones, and evidence requirements.
We help you build the QMS, submission structure, and clinical / regulatory artifacts.
Continued support for regulators, auditors, and investor diligence.
A structure that delivers senior-level regulatory leadership — without the cost or friction of a full-time hire.